Pre-Budget Expectations For The Health And Wellbeing Sector
Regarding this, Siddharth Singhal, Co-founder and CEO of Vibcare Pharma said that, "As the CEO of Vibcare Pharma, I am eagerly anticipating the Indian Budget 2024. This budget is a pivotal moment for the pharmaceutical industry, reflecting the government's dedication to enhancing healthcare. The budget's emphasis on research and development offers us an exceptional chance to innovate. We hope to see increased government backing in areas vital to us, such as regulatory reforms and more healthcare funding. This support is crucial for us to address the dynamic healthcare needs of India. By focusing on advanced R&D, we aim to introduce better and more cost-effective medicines, benefiting both Vibcare Pharma and the community at large.
Furthermore, this budget's healthcare focus aligns with our mission, promising growth opportunities and reinforcing our dedication to providing accessible healthcare solutions.
Looking ahead, we're excited about the prospects this budget holds for our sector, ready to harness these opportunities for continuous growth and innovation. Our pre-budget expectations include government support in critical areas like R&D funding, streamlined regulations, and domestic manufacturing promotion, which will empower our growth and contribute to making healthcare more accessible and affordable in India.
The forthcoming budget presents a transformative opportunity for the pharmaceutical industry to excel in innovation, sustainability, and global competitiveness, further strengthening India's position as a pharmacy of the world."
